Vaxdyn raises €11M Series A to test AMR vaccine
This funding round marks a critical step in Vaxdyn’s evolution into a clinical-stage company, allowing us to clinically validate a…
BEAM at work
Our advocacy work is based on analysis and reflection with our members.
Each topic is dealt with by a task force, which acts as a discussion platform and issues policy briefs.
